A lab-made copy of the most active part of a natural human repair protein, promoted for injury healing and longevity. Animal data are strong, but human proof for the injected form is essentially absent; the best human evidence is an eye-drop of the full protein. Main hazards: unregulated product quality and a theoretical cancer concern. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Complete Blood Count (CBC) | Within lab reference; no unexplained shifts | Screen for infection and hematologic changes during injectable use |
| High-sensitivity CRP (hs-CRP) | <1.0 mg/L | Track systemic inflammation given the peptide's anti-inflammatory claim |
| Comprehensive Metabolic Panel (CMP) | Within lab reference | Baseline liver and kidney function for overall safety surveillance |
| PSA (males) / age-appropriate cancer screening | Age-appropriate reference; no rising trend | Surveillance for the theoretical pro-tumor concern |
| Fasting glucose / HbA1c | Glucose 70–90 mg/dL; HbA1c <5.4% | Baseline metabolic health, relevant to healing capacity |
Cadence: Baseline, then approximately every 8–12 weeks during active use, then at least annually if use continues, with age-appropriate cancer screening kept current.